DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slipped 1.21% to $24.54 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.51% to 19,100.94 and Dow Jones Industrial Average falling 0.58% to 42,098.70.
The stock's fall snapped a two-day winning streak.
Catalyst Pharmaceuticals Inc. closed 6.19% short of its 52-week high of $26.16, which the company reached on March 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.54% to $152.43, Pfizer Inc. $(PFE)$ fell 1.82% to $23.18, and Abbott Laboratories $(ABT)$ fell 0.69% to $132.02.
Trading volume (684,838) remained 593,826 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 28, 2025 17:25 ET (21:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。